Tag: guardant-health

By Julie Steenhuysen CHICAGO (Reuters) – A large study sponsored by privately held Guardant Health Inc of California showed that its Guardant360 liquid biopsy test, which looks at bits of tumor DNA in blood samples, closely mirrored the cancer genes taken from traditional tissue biopsies. The findings, presented on Saturday at the American Society of…